In particular, α-hydroxisobutyrate has been associated with increased insulin resistance and in vitro treatment of pancreatic β-cells with α-hydroxisobutyrate inhibited glucose-mediated insulin secretion [26]. This evidence concerns the gene INS and Insulin resistance.